Lipid profile in the severely obese: Changes with weight loss after lap-band surgery

Obesity Research

Volumn 10, Issue 9, 2002, Pages 903-910

  Dixon, John B ^a   O'Brien, Paul E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Distribution; Gastric; Insulin; Metabolic; Risk

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DIET RESTRICTION; FEMALE; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MORBID OBESITY; SEXUAL DEVELOPMENT; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; FASTING; FEMALE; GASTROPLASTY; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; SEX CHARACTERISTICS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0036727904     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.124     Document Type: Article

References (29)

1. Lamarche B, Lemieux I, Després JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab. 1999;25:199-211.
2. Dixon JB, O'Brien P. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2). Int J Obes Relat Metab Disord. 2001;25:793-7.
3. Koba S, Hirano T, Sakaue T, et al. Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels. J Cardiol. 2000;36: 371-8.
4. Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173-9.
5. Rossner S, Bjorvell H. Early and late effects of weight loss on lipoprotein metabolism in severe obesity. Atherosclerosis. 1987;64:125-30.
6. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res. 1999;7:477-84.
7. Wolf AM, Beisiegel U, Kortner B, Kuhlmann HW. Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg. 1998;8:9-13.
8. Ranlov PJ. Serum lipid changes after gastroplasty for morbid obesity. Acta Med Scand. 1984;216:503-8.
9. Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4:464-9.
10. Buchwald H, Schone JL. Gastric obesity surgery combined with partial ileal bypass for hypercholesterolemia. Obes Surg. 1997;7:313-6.
11. Kelly TM, Jones SB. Changes in serum lipids after gastric bypass surgery. Lack of a relationship to weight loss. Int J Obes Relat Metab Disord. 1986;10:443-52.
12. Busetto L, Pisent C, Rinaldi D, et al. Variation in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss. Obes Surg. 2000;10:569-77.
13. O'Brien P, Brown W, Smith A, McMurrick P, Stephens M. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg. 1999;86:113-8.
14. Medical Outcomes Trust. Scoring Exercise for the SF-36 Health Survey, 2nd ed. Boston, MA: Medical Outcomes Trust: 1994.
15. Burtis CA, Ashwood E, eds. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia, PA: Lippincott; 1986.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
17. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program [letter]. Diabetes Care. 1998;21:2191-2.
18. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.
19. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes. 1999;48: 1779-86.
20. Colman P, Thomas D, Zimmet P, Welborne T, Garcia-Webb P, Moore M. New classification and criteria for diagnosis of diabetes. Med J Aust. 1999;170:375-8.
21. Metropolitan Life Foundation. Height and Weight Tables. New York: Metropolitan Life Insurance Company; 1983.
22. SPSS. SPSS for Windows [program]. Version 10.0.5. Chicago, IL: SPSS Inc.; 1999.
23. Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg. 1998;8:487-99.
24. Dixon JB, Dixon ME, O'Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg. 2001;11:200-7.
25. Nanji AA, Freeman JB. Rate of weight loss after vertical banded gastroplasty in morbid obesity: relationship to serum lipids and uric acid. Int Surg. 1985;70:323-5.
26. Nedelnikova K, Svacina S, Haas T, Matoulek M, Fried M. Influence of metabolic state and diabetes on the outcome at the end of first year after gastric banding. Obes Surg. 2000;10: 372-5.
27. Khan MA, St. Peter JV, Breen GA, Hartley GG, Vessey JT. Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants. Obes Res. 2000;8:43-8.
28. Dart AM, Cooper B. Independent effects of Apo E phenotype and plasma triglyceride on lipoprotein particle sizes in the fasting and postprandial states. Arterioscler Thromb Vasc Biol. 1999;19:2465-73.
29. Krauss RM. Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr. 2001;131:3405-35.